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Bronchopleural fistula (BPF) after a pulmonary resection is rare with some of 
the most life-threatening consequences and a high mortality rate. Contamination 
of the pleural space resulting in empyema and spillage of the infected fluid into the 
remaining lung leading to respiratory distress remain the biggest concerns with BPF 
postoperatively. There are many patient characteristics and risk factors that can be 
evaluated to decrease the chance of a postoperative BPF. Presentation of BPF can be 
early or late with the late BPF more difficult to diagnosis and manage. Many options 
to treat BPF include surgical repair, conservative management, and endoscopic 
treatment.
Keywords: bronchopleural fistula, pneumonectomy, empyema, lung cancer,  
thoracic surgery
1. Introduction
Bronchopleural fistula (BPF) is defined as a central fistulous connection of 
inspired air between trachea, major, lobar, or segmental bronchus into the pleural 
space [1, 2]. Or a BPF can occur peripherally when there are connections between 
the distal segmental bronchus or lung parenchyma and the pleural space [1, 2]. 
Although rare, managing a BPF is challenging and represents a high morbidity and 
mortality.
2. Etiology
After an anatomical lung resection, a BPF is rare but severe complications can 
occur and may be fatal. The BPF incidence after a pneumonectomy for lung cancer 
is between 4.5% and 20% and 0.5–1% after a lobectomy [1, 3, 4]. The mortality rate 
after a pneumonectomy is estimated to be 18–71% with a much lower rate for lobec-
tomy [2, 4]. The pleural space is exposed to the endobronchial bacterial flora with 
the pleural effusion leaking into the major airway and into the peripheral alveolar 
space. The main cause of death is aspiration pneumonia, empyema, and subsequent 
respiratory distress [4, 5]. Treatment for BPF after surgery requires emergency 
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treatment due to patient’s lung volume loss and short-term poor respiratory func-
tion with surgical damage to the respiratory muscles [5].
The less common causes of BPF include suppurative lung processes such as 
septic pulmonary emboli, infected pulmonary infarctions, or tuberculosis [6]. 
Neoplasms with tumor invasion into the pleural space may also lead to BPF. 
Iatrogenic etiologies due to complications with chest tube insertion, thoracentesis 
or lung biopsies may result in BPF [6].
When considering different surgical approaches and incidence of BPF, one 
study evaluated the Society of Thoracic Surgeons and General Thoracic Surgery 
Database (STS-GTD) to compare outcomes of video-assisted thoracoscopic surgery 
(VATS) and robotic-assisted lobectomy (RATS) for primary clinical stage I or II 
non-small cell lung cancer (NSCLC) at high volume centers from 2009 to 2013. 
This study identified 1,220 RATS and 12,378 VATS patients. The incidence of BPF 
between these two groups was not statistically significant (0.6% vs. 0.3%, p = 0.08) 
[7]. Another study that included 737 cases of VATS lobectomies and 748 cases of 
open lobectomies for the surgical treatment of resectable non-small cell lung cancer 
showed no statistical difference in incidence of BPF postoperatively [8].
3. Risk factors
Certain anatomic, technical, and patient factors lead to increased risk for BPF 
(Table 1). Generally, right-sided pneumonectomy is associated with high risk of 
BPF. Devascularization of the bronchial stump, diabetes, malnutrition, steroids, 
neoadjuvant chemoradiotherapy, stump closure, residual carcinomatous tissue, 
presence of empyema and postoperative mechanical ventilation all lead to increased 
risk of bronchial stump dehiscence [9, 10].
3.1 Right sided surgery and right pneumonectomy
Generally, right-side pneumonectomy and right lower lobectomy are associ-
ated with high risk of BPF and are multifactorial. The right upper pulmonary 
artery is made up of the apical, anterior, and posterior ascending branches [11]. 
The apical and anterior branches are located in the front of the hilum and the 
posterior is located at the posterior segment of the horizontal fissure [11]. The 
right lower pulmonary artery is divided into the dorsal and basilar segment and 
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the horizontal fissure [11]. This single bronchial artery supplies the entire right 
mainstem bronchus whereas the left mainstem bronchus has a vascular supply by 
two bronchial arteries [9]. During lymphadenectomy if the single artery of the 
right bronchus is damaged, the bronchial stump becomes ischemic [4].
After a right pneumonectomy, the risk for BPF increases due to the diversion of 
the entire cardiac output going through the smaller left lung and increased load on 
the right ventricle [12]. This compensation results in decreasing circulating blood 
volume, pulmonary hypertension, increased pulmonary pressures, increased pulmo-
nary vascular resistance and right ventricular failure [12, 13]. Loss of the larger right 
lung may compromise pulmonary function resulting in respiratory failure predis-
posing the patient to the postpneumonectomy edema syndrome [12, 14, 15]. Larger 
perioperative fluid resuscitation causes overload of the pulmonary circulation and 
right ventricle and has been reported to be a poor outcome predictor [14, 15].
Anatomical differences in the right bronchus versus the left are significant factors 
in increased risk of BPF. The right main bronchus is more vertical and wider than the 
left increasing the accumulation of secretions in the bronchial stump [4]. The right 
mainstem bronchus is not naturally buttressed by mediastinal tissue coverage and 
therefore likely to be exposed to the thoracic pleural free space [9, 15]. The left main 
bronchial stump tends to be protected and covered by the aortic arch with its sur-
rounding vascularized mediastinal tissue [9, 15]. The left bronchial stump retracts 
within that tissue under the aortic arch after dissection giving protection from the 
pleural free space.
3.2 Lymph node dissection
The surgical approach to mediastinal lymph node dissection at the time of 
pulmonary resection for NSCLC has been a subject of interest for several decades. 
Accurate pathologic lymph node examination offers the most accurate staging and 
survival benefit and provides the most significant prognostic factor [16]. Accurate 
nodal staging increases survival by improved risk categorization, increased detec-
tion of candidates for adjuvant therapy and possibly resection of oligometastatic 
disease [17]. Staging NSCLC may have lymph node metastases even after appearing 
localized by imaging which makes the extent of mediastinal lymph node removal 
controversial [18]. Patients with negative nodes by systematic lymph node dis-
section with early stage NSCLC did not have improved survival with complete 
mediastinal lymph node dissection [17–19]. Intraoperative lymph node sampling 
is removal of one or more lymph nodes decided by preoperative or intraoperative 
findings and is determined by the surgeon [19]. Systematic nodal dissection con-
tains all mediastinal tissue containing lymph nodes and is removed systematically 
within anatomical landmarks. To meet minimal recommendations, for right-sided 
cancers, mediastinal lymphadenectomy should contain stations 2R, 4R, 7, 8, and 
9. Left side stations 4 L, 5, 6, 7, 8 and 9 should be included [17–19]. Patients should 
have N1 and N2 node resection with a minimum of N2 stations sampled [17–19]. 
Some argue that systematic mediastinal lymph node sampling versus mediastinal 
lymph node dissection is adequate for staging and that complete dissection does 
not provide survival advantage as most patients with N2 disease die from systemic 
disease [18, 19].
Lymph node dissection removes tissue from adjacent organs and skeletonization 
of intrathoracic structures. It includes enblock removal of tissues with cancer cells 
that includes lymph nodes and fatty tissue within bronchus, trachea, superior vena 
cava, aorta, pulmonary vessels, and pericardium [17, 20].
Healing of the bronchial stump is delayed due to decreased post-operative blood 
supply after lymph node dissection. Superior and inferior mediastinal lymph node 
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dissection for NSCLC is widely performed adjunct to pulmonary resection [21]. 
Vascular supply to the suture line is watershed from the descending thoracic aorta 
across the mediastinum and is decreased after mediastinal lymph node dissection 
[11]. Ischemic bronchitis after lymph node dissection due to decreased bronchial 
microvascularization negatively influences bronchial stump healing [11, 21]. Lymph 
node sampling rather than complete lymphadenectomy leading to devascularization 
of the bronchial stump can permit adequate blood flow to the bronchial stump [21]. 
Meticulous technique while dissecting around the bronchus is necessary. Preventing 
devascularization of the bronchus during lymph node dissection can decrease the 
incidence of fistulization [9, 21].
3.3 Stump closure
The Sweet principles on bronchial closure, emphasized in 1945 are still followed 
today. Trauma to the end of the bronchus should be minimized and the blood sup-
ply must be preserved all the way to the end cut of the bronchus [22]. The cut edges 
of the bronchus should be carefully approximated [22]. Tissue reinforcement of the 
bronchial closure should be provided. Clamps should not be used on the proximal 
bronchus [22]. The major change to Sweet’s original description has been leaving 
the posterior membranous wall longer when cutting the bronchus so it can be used 
as a flap to decrease tension on the closure [22].
Typically, when the bronchus is pulled to place a stapler, an abrupt onset of 
vagal-induced atrial fibrillation or bradycardia may occur, along with hypoten-
sion that leads to releasing the bronchus [23]. There is a natural tendency with 
the next attempt to reduce bronchial traction allowing for a longer stump. Using a 
Roticulator linear stapler is useful to suture and clip the main bronchus close to the 
carina [23]. To avoid pooling of secretions within the bronchial stump, the stump 
should be resected back to its origin and for a pneumonectomy divided as close to 
the level of the carina as possible [9, 24]. This is critical to avoid secretions pooling 
resulting in infection and stump breakdown.
When closing a very proximal right bronchial stump or thickened bronchial 
wall, attention must be directed to ensure there is no closure under tension [25]. 
Closure under tension can be implicated in right sided BPFs at the point of transec-
tion of the right mainstem bronchus as it is generally larger than the left [25]. By the 
Law of LaPlace, the tension on the curved cartilaginous membranes and the fluid 
within the crenelated surface is higher in the larger orifice of the right bronchial 
stump [18, 26, 27]. Elimination of the stump diverticulum may reduce surgical 
line tension [18, 26, 27]. The cartilaginous ring at the origin of the right mainstem 
bronchus tends to keep the bronchus open and closure should be parallel to the 
bifurcation spur of the resected bronchus [21, 28]. This decreases the intraluminal 
deformity of the remaining bronchi with the straightened angle of the longitudinal 
axes [21,28].
3.3.1 Suture vs. staple closure
The surgical technique of bronchial closure remains controversial and has been 
studied extensively. The preferred technique of pulmonary hilum vessel ligation 
and bronchial stump closure has troubled thoracic surgeons for years. In 1909, 
regarding bronchial stump closure, Meyer advised his inversion technique [29]. 
In 1945, Sweet described the longitudinal, single interrupted silk suture closure 
[29, 30]. Dr. Mark Ravitch started using staplers in the United States in 1964 after 
having observed their early development in Russia [29]. In 1970, Kirksey reported 
147 patients who underwent pulmonary resection with disposable and plastic 
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American staplers called Thoraco-Abdominal (TA) [29]. Reluctance to use vascular 
staplers due to fear of fatal hemorrhage because of malfunction continued the 
debate concerning pulmonary hilum vessel manual ligation versus stapled division 
for many decades [29]. The cessation of the alarm resulted after Asamura et al., in 
2002 published results of 842 vascular divisions using endoscopic staples with 0.1% 
incidence of stapling failure and Yano et al., in 2013 reported 3393 pulmonary vein 
and artery stapling uses with a failure rate of only 0.27% [29].
It is decided by the surgeon perioperatively to use either manual suturing or sta-
pling methods [31]. None of these have proven superiority in reducing the incidence 
of BPF and around a 4% rate of BPF has been reported for mechanical stapling and 
suture technique [31, 32]. Ucvet et al., 2011 reported the weakest part of the line are 
the end points of the stapler and it may incompletely close the tissue [31]. The staple 
line that exceeded the length of the bronchus caused a detachment in this end site 
creating a microfistula. These microfistulas can lead to large BPF along with infec-
tions [31]. To provide stump safety, lateral suturing to the weak and risky stump 
end points was required [31].
Endoscopic staplers have 2 differences compared to conventional TA type 
staplers: proximal and distal ends can be closed, both division and stapling can be 
performed simultaneously in one firing motion [31, 33]. The advantages of using 
endostaplers during a pulmonary resection are: (1) Time required for closure can be 
reduced, compared to the TA stapler when closure of the distal end of the bronchus 
and division are required; (2) Both proximal and distal ends of the bronchi are 
simultaneously and tightly closed without purulent or contaminated discharge 
which minimizes contamination of the operative field; (3) By selecting the appro-
priate cartridges, endostaplers can be used safely in vascular division [31, 33].
Suture closure is considered when the bronchial wall is hardened due to cal-
cification [10, 21, 33]. Suture closure is also used with position difficulty due to 
hilar adenopathy or when the tumor is close to the pulmonary hilum due to a more 
extensive proximal dissection or a technically difficult bronchial stump [10, 21, 33]. 
Manual suturing may have the advantage of allowing inspection and assessment 
of the bronchial mucosa quality. Tumor fragments may also be recovered after the 
main bronchus is clamped [34].
3.4 Tissue coverage of the bronchial stump
Generally, wound healing has three phases: (1) inflammatory phase (2) prolifera-
tion phase (3) remodeling phase [35]. The inflammatory phase is marked by the 
aggregation of platelets, infiltration with leukocytes and coagulation. This phase 
begins soon after injury and is followed by the proliferation phase. The proliferation 
phase is characterized by reepithelialization, fibroplasia, angiogenesis, and wound 
contraction. Persistent inflammation can last about 2 weeks and likely causes robust 
adhesion. The remodeling phase takes place over months when the epithelium pro-
duces collagen and matrix proteins responding to the injury [35]. The phase of wound 
healing needs to be considered when deciding which type of bronchial closure is used.
Several options are available for coverage of bronchial closure. To reduce the 
incidence of postpneumonectomy BPF with soft tissue buttressing after bronchial 
closure has been debated. Many suggest stump reinforcement in patients with 
increased risk factors for BPF [36]. Cerfolio et al., 2005 suggests the best way to 
treat postoperative complications is to prevent it [37]. Local soft tissue coverage 
may provide vascular ingrowth to promote stump healing and effectively contain a 
small bronchial stump dehiscence [38]. Algar et al. 2001, found that the absence of 
bronchial stump tissue coverage was an independent predictor of BPF in the final 
multivariable model (p = 0.039) [32].
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3.4.1 Intercostal muscle flap
The intercostal muscle flap causes no functional disability, is easy to harvest, 
has adequate length to reach most sites, has adequate vascularity and is harvested 
through the same thoracotomy incision [39]. Sfyridis et al., discovered the group 
that received an intercostal muscle flap had a lower incidence of development of 
BPF (0% versus 8.8%; p < 0.02) [40]. This flap is harvested prior to chest retrac-
tion to not crush the flap and cause damage to the blood supply. The use of cautery 
to harvest this flap is necessary because it is lacking periosteum and over time will 
not calcify [9, 37, 40]. The intercostal muscle flap is harvesting by cutting approxi-
mately two-thirds of the posterior aspect of the latissimus dorsi and the entire 
serratus anterior muscle is spared [37]. The rib is not shingled or cut. For harvest-
ing, rib instruments are not used. The intercostal muscle flap, usually overlying the 
sixth rib is harvested using cautery prior to chest retraction from the under surface 
of the fifth rib. Starting at the distal end of the muscle under the serratus anterior 
muscle, cautery is lowered from 40 to 70 and carefully the muscle is dissected with 
both hot and cold cautery. So the intercostal vein is not injured, the cautery tip is 
positioned so it is almost parallel with the surface of the fifth rib. The intercostal 
is posteriorly freed from the sixth rib, past the lumbar-dorsal fascia but not freed 
from the undersurface of the fifth rib past this structure due to risk of injury to the 
vein posterior of the fifth rib with any further dissection. The bronchial stump is 
then tested [37].
3.4.2 Pericardial fat pad
In a retrospective study, Taghavi et al., found 93 patients who underwent 
pneumonectomy for primary lung cancer, identified no BPF during follow up after 
using a pedicled pericardial flap for bronchial stump coverage [41]. A pericardial 
fat pad is harvested from the anterolateral pericardium, pedicled at its cranial part, 
avoiding inclusion or injury to the phrenic nerve [9, 42]. A wide based pedicle 
should be used to assure vascularity of the flap. Careful attention should be used 
to avoid twisting the pedicle. The flap is attached caplike over the bronchial stump 
with numerous single mattress stitches to avoid devascularization when tied down 
over the four corners of the bronchial stump. The defect in the pericardium is then 
reconstructed with mesh [9, 42].
3.4.3 Serratus anterior flap
Bronchopleural fistula is exceedingly rare when a pedicled muscle flap is used 
to buttress the lobar bronchus, even after preoperative radiation doses of 60Gy or 
higher are administered [43]. To provide sufficient protection after preoperative 
radiation, using omental or serratus as a prophylactic buttress for the highly irradi-
ated right main stem bronchus after a right pneumonectomy is recommended [43].
If the patient is believed to be at extraordinary risk of stump complications, larger 
muscle or omental flaps are used. The serratus anterior flap and omental flap are also 
used to treat a postoperative bronchopleural fistula to close the fistula [43, 44].
The serratus anterior muscle, one of the workhorse flaps is easily harvested, 
reliable, often preserved during the initial pneumonectomy due to its utility in deal-
ing with potential complications [44]. The vascular pedicle that runs on the lateral 
undersurface of the scapula is where the serratus anterior muscle is based [25]. This 
muscle is mobilized and placed between the ribs in the second or third interspace 
where it will reach the hilum without tension. The thoracodorsal vascular pedicle is 
protected throughout the dissection [44]. With tight interspaces, compromising the 
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vascular supply of the flap, a segment of the third rib can be removed to allow the 
flap to enter the pleural space easily [25]. The serratus anterior flap is secured with 
interrupted absorbable sutures to the mediastinal areolar or peribronchial tissue [25] 
(Figure 1). This tissue helps with infection control and healing due to its blood sup-
ply emanating from regions beyond the inflamed field [25]. The flap is placed over 
the bronchial stump with uninterrupted suture to secure the closure [9, 25, 44].
3.4.4 Omental flap
The omentum has superior blood supply and plasticity which allows for a very 
safe and easy bronchus closure even in the presence of fibrotic tissue or infection 
[45]. The omentum with a rich blood supply assures adequate antibiotic and oxygen 
delivery [46]. Delivering potent angiogenic factors, the omentum improves neovas-
cularization of the bronchial suture lines in experimental models. Omental transpo-
sition does not impair muscle function or produce chest wall deformities seen with 
major muscle flaps [46].
The disadvantage of tradition omental flap transposition extends the surgical 
procedure into the abdomen, requiring laparotomic access. Usually the omentum is 
mobilized through the upper midline abdominal incision, transposed into the chest 
via a substernal or anterior transdiaphragmatic route [46]. This description applies 
a transdiaphragmatic harvesting technique of the greater omentum performed 
through the standard thoracotomy [46].
The five centimeter incision in the diaphragm is performed radially between its 
anterior insertion and central tendon through the standard thoracotomy [46, 47]. 
Oval forceps are used to slide through the diaphragm into the abdominal cavity. 
Once confirmation the omentum is free of adhesions, the greater omentum gently 
can be retracted through the diaphragm into the chest. The omental insertion of 
the transverse colon is identified and divided as extensively as possible. The most 
distal omental extremity is identified in the chest cavity by gentle traction and 
subsequently isolated carefully inspecting its vascular supply. After confirming the 
omental flap has no traction on the stomach or colon, the omentum is sutured to the 
bronchial stump in the usual fashion. The diaphragmatic incision is closed leaving 
a large enough opening to avoid strangulation of the omentum. The omental flap 
is sutured with interrupted sutures to the diaphragmatic opening to further relieve 
Figure 1. 
The serratus anterior muscle is harvested and mobilized into the chest between the ribs in the second or third 
interspace with rib segmentation. (Sugarbaker D, Bueno R, Burt B, et al, editors. Adult chest surgery. 3rd 
edition. New York: McGraw-Hill Education; 2020; with permission).
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any tension. This technique is appropriate to reinforce the bronchial stump and can 
be large enough to fill the pleural space [46, 47].
3.5 Residual carcinoma at bronchial margin
Residual disease is characterized by residual carcinomatous tissue within 
the margin of resection either under visible inspection or under microscopy 
[48]. Residual disease at the bronchial stump may cause poor prognosis with the 
increased risk of lung cancer recurrence both distantly and locally [48]. It may also 
decrease the bronchial stump anastomosis which can lead to a fatal bronchopleural 
fistula or empyema [48, 49]. In all pulmonary resections, the estimated incidence 
of residual disease left at the bronchial stump is 4–5% [49]. Asamura et al. reported 
in 2359 patients that the most important risk factor for a BPF was resection type, 
followed by presence of residual microscopic tumor at the resection margin 
(p < 0.01) [28]. Survival is worse in patients with bronchial margin residual disease; 
1 and 5 year survivals range between 20 and 50% and 0–20% respectively [48]. 
Mediastinal lymph node involvement is associated with the poor survival in 75–85% 
of patients with residual bronchial margin disease [48]. Radiotherapy or reopera-
tion may be considered in these patients [48, 49].
3.6 Neoadjuvant chemoradiotherapy
Neoadjuvant chemoradiotherapy is a crucial strategy in multidisciplinary treat-
ments to improve the survival rate and resectability for patients with lung cancer 
[50]. Especially for patients with advanced lung cancer, chemoradiotherapy can 
eliminate or reduce the micro-metastasis. Previously published randomized control 
trials have been integrated with recent systematic reviews and have concluded that 
neoadjuvant chemoradiotherapy can significantly benefit the survival outcomes in 
operable patients [50]. Relative to other pulmonary resections, pneumonectomy has 
been associated with increased morbidity and mortality. The mortality for a pneu-
monectomy after neoadjuvant therapy has reports with very low mortality (<5%) 
countered by other reports with alarmingly high mortality (>20%) [51]. For the 
patient with N2 disease who requires a pneumonectomy, the correct approach can be 
unclear with the postoperative and intraoperative complications remaining a debate 
[50, 51]. Bronchial mucosa ischemia is induced by radiotherapy but the mucosal 
blood flow can recover in eight to ten days after completion of therapy. Early effects 
of radiation can cause mucosal edema and inhibit capillary angiogenesis [52]. Late 
effects of radiation cause fibrotic small vessel disease through radiation vasculopathy 
[52]. Radiation pneumonitis, poor wound healing, and fibrosis can occur in previ-
ously irradiated bronchial tissue with a higher perioperative and postoperative 
complication leading to a bronchopleural fistula [53, 54]. Induction therapy may 
cause injury to the bronchial microvascularization predisposing to airway complica-
tions but published literature does not support the notion that all pneumonectomies 
after therapy are associated with postoperative mortalities [51, 55].
3.7 Empyema
Empyema is the presence of purulent fluid in the postpneumonectomy pleural 
space. Postpneumonectomy empyema occurs in 2–16% of patients and can be 
life threatening [55]. This postoperative complication is associated with BPF 
which can further increase morbidity and mortality [56]. Most BPFs associated 
with empyema is monomicribial with most pathogens being Streptococcus or 
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Staphylococcus species and occur within 10 to 14 days of surgery [52, 57]. A late 
empyema can occur more than three months to 40 years after a pneumonectomy 
and is most often acquired via a hematogenous route [52, 57]. After a pneumonec-
tomy, to avoid spillage of infected fluid into contralateral lung the patient should 
be kept upright at least 45 degrees [52]. An early empyema withing 10 to 14 days 
after surgery presents with expectoration of purulent sputum and fever [57]. 
Radiographic findings show a shift of the mediastinum away from the post-
pneumonectomy space, development of a new or sudden change in the existing 
air-fluid level, and failure of the mediastinum to shift normally in the immediate 
postoperative period [57]. Empyema diagnosis is confirmed by fluid sample in the 
postpneumonectomy space [57].
3.8 Mechanical ventilation
Mechanical ventilation in patients after a pneumonectomy, subjects the bron-
chial stump line to increased wall tension and continuous barotrauma [1]. Positive 
pressure ventilation can be challenging in these patients and the aim is to prevent 
further lung injury by keeping the airway pressure below the critical opening pres-
sure of the fistula, optimizing pleural suction pressures and provide adequate alveo-
lar ventilation of sufficient gas exchange [58, 59]. To decrease the flow across a BPF, 
reducing the proportion of minute ventilation provided by the ventilator, minimal 
levels of positive end expiratory pressure (PEEP), low tidal volumes and respiratory 
rate are helpful [1, 59]. Adverse effects in mechanically ventilated patients with 
BPF include loss of effective tidal volume, incomplete lung expansion, inability to 
remove carbon dioxide and prolonged ventilatory support [59]. The majority of 
reported studies report a significant relationship between the occurrence of BFP 
and mechanical ventilation after pneumonectomy [60].
3.9 Diabetes, chronic steroid use, nutritional status
Typically, surgeons consider diabetes mellitus in patients requiring surgical 
intervention an important contributor to some fatal adverse events [61]. Diabetic 
microangiopathy alters the vascular bed causing small vessel ischemia impairing 
proper wound healing [40]. This decreases the oxygen diffusion capacity and the 
bronchial stump circulation is particularly prone to poor wound healing [52, 61]. 
The largest retrospective analysis reported by Asamura et al. in 1992, showed statis-
tical results from both univariate and multivariate analysis indicating significantly 
increased risk of postoperative BPF in patients with diabetes [28].
Preoperative use of corticosteroids is believed to contribute to several postopera-
tive complications which include impaired bronchial healing [62]. In a study by 
Algar et al. 2001, patients with preoperative steroid therapy were associated with 
higher risk of BPF (p < 0.001) [32]. This same study found hypoalbuminemia to 
also be related to higher risk of BPF (p < 0.017) [32]. Hypoalbuminemia has a nega-
tive effect on the healing process, and in order to decrease the BPF risk, an albumin 
level above 3.5 mg/dl is the goal [63]. Patients requiring a pneumonectomy are 
usually very catabolic and nutritional assessment is essential in their management 
[1]. Metabolic alterations induced by the lung cancer tumor affects the nutrition in 
these patients [64]. These alterations lead to cachexia syndrome with higher levels 
of the proinflammatory cytokines interleukin-6 and tumor necrosis factor and 
lower levels of albumin [64]. Malnutrition increases the risk of 90-day mortality 
rate, postoperative infection and length of hospital stay after a pneumonectomy 
and a thorough preoperative evaluation is crucial [64].
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4. Pathophysiology: clinical features and diagnosis
4.1 Early/acute bronchopleural fistula
An early BPF has a peak incidence within 8 to 12 days after surgery but can 
occur at any time in the postoperative period [59]. Surgical closure of the BPF is the 
cornerstone of management. If a BPF is seen within the first 4 days after surgery, it 
requires exploration as it is likely due to a mechanical failure of the bronchial  
stump [59]. Early BPFs are normally approached urgently through the previous 
thoracotomy incision. An acute BPF can be life-threatening due to asphyxiation 
from pulmonary flooding or tension pneumothorax due to a massive air leak  
[59, 65, 66] (Figure 2). Acute BPF should be suspected in patients who present with 
fever, dyspnea, subcutaneous emphysema, excessively productive cough of puru-
lent fluid, hypotension, trachea or mediastinal shift, disappearance, or reduction 
of pleural effusion on the chest radiograph or persistent air leak [25, 59, 65]. Chest 
radiography monitors the efficacy of BPF therapy and plays an essential role in eval-
uating the possibility of a BPF after a lung resection [2]. These symptoms appearing 
should raise the index of suspicion and quick and accurate diagnosis must be made 
before there is an overwhelming amount of aspiration into the remaining lung [25].
4.2 Late/chronic bronchopleural fistula
Late bronchopleural fistula present in the postoperative period more than 14 days 
[59]. The subacute and chronic forms present with more insidious symptoms and 
is characterized by fever, malaise, wasting, minimally productive cough, dullness 
to percussion on the affected side and reduced air entry with progressive clinical 
deterioration and varying levels of respiratory compromise [2, 59, 65]. A late BPF is 
often seen in debilitated or immunocompromised patients with many comorbidities 
[59]. In the chronic form that is associated with empyema, there is fibrosis of the 
mediastinum and pleural space preventing the mediastinal shift [59, 65].
Causes of late BPF include foreign body aspiration, refractory infection, che-
motherapy and radiotherapy, and blunt chest trauma [67]. The time of interval is 
2 months to 20 years between the surgery, therapy or injury and the onset of the late 
BPF [67].
Figure 2. 
Axial lung window after right pneumonectomy with large pneumothorax with evidence suggesting 
communication of the bronchial stump and pleural space. Case courtesy of Radswiki, Radiopaedia.org, 
rID: 11262.
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In late BPF, due to the relatively stable mediastinal structures, conservative 
treatment is accepted by many investigators as the first step. Closure of the bron-
chial fistula with endoscopic treatment should be considered [67]. Proper antimi-
crobial coverage is mandatory along with proper nutrition with patients frequently 
requiring parenteral or enteral feeding [65]. Aggressive nutritional support and 
physical rehabilitation should be started early to optimize patients and enhance 
their recovery [65]. If surgery is indicated for a late BPF, the previous transthoracic 
approach may be unsafe due to fibrosis with associated inflammation with risk 
of bleeding and injury to vital structures [68, 69]. With a median sternotomy, 
approaching well vascularized, healthy, virgin tissues to reach the carina and bron-
chi may be preferrable and necessary. The advantages to the transsternal approach 
for BPF closure are avoidance of an inflamed operative field, scarring and adhesions 
in previous surgical fields and deformities of the thorax with thoracoplasty [68, 69]. 
The disadvantage of this approach is the infected empyema space is not managed at 
the time of closure. Previous cardiac surgery is not recommended for this type of 
approach [68, 69].
Once a BPF is suspected, a Computerized Tomography (CT) Scan with intrave-
nous contrast to map the vasculature and better define the air-fluid levels and the 
peripheral rind enhancement is necessary [70]. This scan will identify the fistulous 
tract and will allow evaluation of the potential causes of BPF (i.e. recurrent tumor, 
staple line dehiscence, pneumonia, abscess, devascularized stump). It will also be 
simultaneously used to define the anatomic relationship of the adjacent mediastinal 
structures, vasculature, and diaphragm. A large fistulous tract can be clearly identi-
fied and a vigilant search must take place to look for subtle signs of a small BPF such 
as a change in the appearance of pre-existing pleural air-fluid levels and extralumi-
nal air bubbles adjacent to the bronchial stump. Care must be taken to ensure while 
the patient is lying flat during the scan that they do not aspirate the pleural fluid 
through the BPF to the healthy lung [70].
All patients should undergo diagnostic bronchoscopy whether the BPF diagnosis 
is apparent radiographically or clinically [25]. A large fistula can be visualized but 
smaller 1 to 2 mm fistulas may be difficult to recognize [25]. Bronchoscopy provides 
information about the tissue at the level of the stump and condition of the remain-
ing bronchial stump and can assist in deciding definitive repair [25].
5. Management of BPF
Management varies according to the individual patient, but the importance of 
addressing the risk of contralateral aspiration pneumonia and tension pneumo-
thorax by drainage of the pleural space at time of diagnosis has to be emphasized 
[69]. The most important action when an acute BPF is suspected is protecting the 
contralateral lung from spillage of pleural fluid [2]. The primary principle is drain-
age of the pleural space by chest tube thoracostomy and care should be taken to 
place the chest tube above the previous thoracotomy incision as the diaphragm will 
be elevated with the normal thoracic remodeling that occurs after pneumonectomy 
[25, 59, 71, 72]. Pleural fluid should be sent for total protein, complete blood cell 
count, glucose, cytology, lactate dehydrogenase, triglycerides, gram stain and cul-
ture to evaluate for pleural infection [59]. Although integral for drainage, the chest 
tube can predispose the pleural space to infection and function as a foreign body 
[59]. Connecting the chest tube to a digital chest drainage system allows for more 
accurate and objective assessment of air flow and larger flow values and trend 
evaluation would provide more detailed information about the size and severity 
of the BPF [73]. For patients who are mechanically ventilated, the chest tube can 
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be used for occlusion during the inspiratory phase or to add positive intrapleural 
pressure during the expiratory phase [59]. These interventions decrease BPF 
during inspiration and decrease air leak during expiration to maintain positive 
end-expiratory pressure (PEEP) [59].
5.1 Acute failure of the bronchial stump
Acute failure of the bronchial stump is usually due to bronchial stump dehiscence 
and expeditious surgical repair with this single-staged intervention is recommended 
once clinical stabilization is achieved [71, 74, 75]. Given the relative integrity of the 
tissue, early stage of the infectious process, minimal pleural contamination and no 
problematic residual space, early reoperation is warranted to reestablish an airtight 
stump [25, 71, 74, 75]. Exploration with surgical revision by posterolateral thora-
cotomy with selective intubation and lung isolation of the contralateral mainstem 
bronchus to prevent further spillage of the remaining lung is recommended  
[25, 71, 75]. The fistula, if not readily visible can be identified with the assistance of 
positive pressure ventilation while covering the bronchial stump with irrigation [25]. 
The pleural space should be completely debrided and irrigated to remove all necrotic 
tissue [25]. The bronchial stump is refashioned and carefully dissected to decrease 
trauma to the blood supply [25, 71]. Measured from the carina, all efforts are made 
to made for the final stump to be less than 1 cm in length [25] (Figure 3). The stump 
may be reclosed with a stapler if their remains sufficient length on initial exploration. 
In cases where there is too much inflammation to allow stapling, the bronchial stump 
is mobilized and reclosed with interrupted monofilament sutures [25, 71]. A balance 
between avoiding too much exposure that may damage blood supply and exposing 
enough bronchus to avoid tension on the closure much be achieved [25].
5.2 Transposition of muscle flaps to treat BPF
Using a vascularized tissue to reinforce the suture line is the most important 
aspect of closure [25, 76]. Stump coverage was previously discussed as a preven-
tive measure for BPF. The objective in treating a BPF with vascularized tissue is to 
obliterate the postpneumonectomy pleural space [25, 71, 75, 77]. Deciding which 
muscle flap to use depends on which muscle was preserved or damaged from the 
previous thoracotomy and the amount of space to be filled [71, 75, 77]. The most 
common muscles used in the pleural space to treat a BPF are serratus anterior, 
pectoralis major, pectoralis minor, latissimus dorsi, and intercostal muscles  
[25, 71, 75, 77, 78]. The latissimus dorsi is the most reliable and largest muscle but 
Figure 3. 
A. The bronchial stump should be less than 1 cm. After inspection, if there is enough length on the stump, it 
can be closed with a stapling device. B. With too much inflammation, the stump may need to be sutured closed. 
(Sugarbaker D, Bueno R, Burt B,  et al, editors. Adult chest surgery. 3rd edition. New York: McGraw-Hill 
Education; 2020; with permission).
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may not be sufficient to obliterate the postpneumonectomy cavity if it was already 
divided in the original thoracotomy [77, 78]. The greater omentum consists of 
a large fold of peritoneum with excellent blood supply and antibacterial effect, 
lymphoid tissue, and fat [76, 78]. Using large muscles as the latissimus dorsi, 
greater omentum and serratus anterior has the advantage to contribute bulk to fill 
some of the dead postpneumonectomy space sugar [76–78]. In a study by Mazzella 
et al. 2017, fourteen patients with early BPF were treated with surgical repair of 
the bronchial stump via thoracoscopy (2) or thoracotomy (12) with omentum and 
fibrin glue (2) parietal pleural (3), intercostal muscle (1) or pericardial patch (2) 
with no recurrence of BPF after surgery [79].
5.3 Clagett window and eloesser flap
Treating a BPF with empyema and sepsis may require an Eloesser flap for 
patients too debilitated or too ill for a decortication or prolonged procedure involv-
ing muscle flaps [25, 80, 81]. The difference between the Clagett open-window 
thoracostomy (OWT) procedure and Eloesser flap is that the Clagett procedure is 
larger than the Eloesser flap and the Clagett window is temporary to allow complete 
drainage of purulent drainage in the pleural space [80] (Figure 4). The Eloesser flap 
creates a permanent drainage window in the pleural space [80].
5.3.1 Clagett procedure
In 1963, Clagett and Geraci described a technique as a two-step procedure for the 
management of postpneumonectomy empyema [81, 82]. This procedure combined 
an open-window thoracostomy pleural drainage with repetitive irrigation of the 
infected cavity with obliteration of the space with antibiotic fluid without direct 
fistula closure [2, 25, 81–84]. The procedure resulted in recurrences of fistulization 
and prolonged hospitalization and significant mortality. This technique is rarely 
Figure 4. 
(A) Clagett window and (B) Eloesser flap. (Sugarbaker D, Bueno R, Colson Y, et al, editors. Adult chest 
surgery. 2nd edition. New York: McGraw-Hill Education; 2015; with permission).
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used and has been modified with initial bronchial stump closure with muscle 
transposition described earlier [2, 25, 80–84].
Once the BPF is closed and buttressed with muscle transposition, diluted wet 
povidone-iodine (Betadine) dressings are placed in the thorax and changed every 
48 hours in the operating room [81, 83, 84]. This is done for approximately 4 to 6 days 
until the muscle flap is adherent to the bronchial stump and adjacent mediastinum 
[81, 83, 84]. Then the pack is changed in the patient’s room 3 to 4 times a day. When 
health granulation is present in the pleural space, the entire cavity is filled with 
antibiotic solution selected to tailor culture and sensitivity results [25, 81, 83, 84]. In 
multiple layers to avoid leakage of fluid, the chest is then closed [25, 81, 83, 84].
The modified Clagett procedure involves daily intracavitary dressing changes, 
lasting for a long period of time and may not allow chest closure. Other ways to 
accelerate wound healing process were investigated [85]. Wound vacuum-assisted 
closure (VAC) therapy has recently been evaluated and used in patients with 
complex infected wounds without the OWT [86]. Bacterial proteinases are microor-
ganisms and play a pathogenic role in an infected wound by consuming oxygen and 
nutrients that are required for tissue repair [87]. Reducing the bacterial proteinase 
load in a wound would allow the body to heal [87]. The VAC allows topical solutions 
to be cyclically flushed into the foam dressing before removal under negative pres-
sure that irrigates, cleans, and removes infectious material from the pleural space 
[85, 87]. This is done without OWT, decreasing postoperative pain [88]. Recent 
studies show that as an adjunct to standard therapy, the VAC can decrease pain, 
hospital length of stay and morbidity in patients with complicated postoperative 
empyema [85, 88].
5.3.2 Eloesser flap
The Eloesser Flap OWT continues to evolve. A “H” or “U” shaped incision is 
made above the previous incision over the dependent portion of the space [25, 80]. 
A segmentary resection of one or two ribs are removed to obtain a window and 
limit the tendency of the opening to contract and close [25, 79, 80]. Necrotic tissue 
is debrided and edges of the flap are sutured directly to the parietal pleura with 
absorbable interrupted sutures to create an epithelized tract which encourages heal-
ing and maintains window patency [25, 79, 80]. The window should be not too far 
inferiorly which may interfere with the diaphragm and not too posterior that would 
be difficult for the patient to manage [25, 79, 80]. Using moistened gauze, dressing 
changes are performed until the cavity is decontaminated. Care is taken to prevent 
cardiac tamponade by excessive gauze inserted in the cavity [25, 79, 80]. The thora-
costomy is closed with a thoracomyoplasty when clinical conditions suggest correct 
timing. In the chest cavity, healthy granulation tissue, improved clinical condition, 
closure of the bronchial stump and negative cultures of the chest cavity all suggest 
proper timing [25, 79, 80].
6. Endoscopic treatment of bronchopleural fistula
6.1 Biological glue
Many different biological glues for endoscopic BPF closure are available. Fibrin-
based, albumin-glutaraldehyde tissue adhesive, and cyanoacrylate-based glues are 
the most common [2, 83]. Application technique is performed by a catheter inserted 
through the flexible bronchoscope and placed above the fistula [2, 83]. The glue 
is injected into the fistula and creates a plug after a few seconds that occludes the 
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fistula with instantaneous cessation of air leak expected [2, 83]. Some prefer glue 
injection with a 21G needle due to less glue displacement and more effective closing 
of the BPF. This procedure may need to be repeated and endoscopic surveillance 
and close clinical monitoring is important for signs of failure [2, 83].
Cardillo et al. 2015, reported patients with BPF sized 1 cm or less with a viable 
bronchial stump were treated endoscopically [89]. The cure rate with endoscopic 
treatment was 92.3% in very small fistulas <2 mm with mechanical abrasion of the 
fistula. Cure rate was 71.4% in small fistulas >2 mm and < 3 mm with submucosal 
injection of 0.5 to 2 mL polidocanolhydroxypolyethoxydodecane at the fistula. This 
liquid surfactant causes endothelial cell lysis. It induces sclerosis and acts on the 
venous endothelium via interferences with cell membrane lipids. Cure rate with 
intermediate fistulas >3 mm and < 6 mm was 80%. Treatment was with n-butyl 
cyanoacrylate glue injected into the fistula. This mechanically occludes the fistula 
causing proliferation of the bronchial mucosa and a local inflammatory reaction. 
Morbidity and mortality rates were 5.8% [89].
6.2 Endobronchial valves
Endobronchial valves (EBV) have been available since 2003 and were originally 
developed for the reduction of lung volume in patients with emphysema [90, 91]. 
They were first described by Snell et al., 2005 for BPF [92]. Introduced through 
a flexible bronchoscope, EBV have a unidirectional valve to prevent airflow into 
the fistula and will result in atelectasis and collapse of the fistula [90, 91, 93]. 
This results in decreased or absent air leak. The process of recovery would lead to 
resolution of the shunt, fibrosis, and eventual extraction of the EBV [90, 91, 93]. 
Complete elimination of air flow through the BPF does not always occur and does 
not mean the EBV is unsuccessful. Decreased flows may bring the rate below critical 
rate flows and allow for fistula healing [91].
6.3 Amplatzer device closure
Many small fistulas (<3 mm) spontaneously heal or heal with glue placed endo-
scopically [94, 95]. Treatment for BPF endoscopically can bridge to control infection 
until a patient is able to able to undergo surgical repair [90, 92] (Figure 5). Amplatzer 
Figure 5. 
Amplatzer Muscular VSD Occluder 8mm x 7mm placed to occlude the right mainstem bronchopleural fistula. 
Image courtesy of Dr. Tarek Dammad, Orlando, Florida.




Division of Cardiothoracic Surgery, AdventHealth Hospital, Orlando, FL, USA
*Address all correspondence to: kristina.jacobsen@adventhealth.com
device is normally used for transcatheter closure of atrial septal defects. This device 
can contribute to intrabronchial granulation tissue and has good biocompatibility [94, 
95]. The tissue growth reduces the risk of displacement. The waist of the Amplatzer 
device is placed inside the fistula and the two discs are placed at the distal and 
proximal ends of the fistula [94, 95]. Fruehter et al. 2011 treated nine patients with 
Amplazter device with BPF and the fistula was successfully closed [96]. After nine 
months, the results were maintained [96].
7. Conclusion
Improvements in thoracic surgery have decreased the incidence of BPF but 
mortality remains high. Proactive approaches to risk management and mitigating 
potential causes for increased chance for BPF preoperatively and intraoperatively are 
essential to improved outcomes. Expeditious surgical repair for acute BPF, along with 
new therapies with wound vacuum-assisted closure (VAC) therapy and endoscopic 
options for small fistulas may all expedite closure of BPF and improve survival.
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